home All News open_in_new Full Article

Dobber (AstraZeneca): "Europa ha elevado su inversión en defensa y ahora debe también proteger su soberanía sanitaria"

El directivo considera que hay que "reequilibrar el coste de la innovación entre los países de renta alta". Más información: Roach (Sanofi), ante la guerra comercial: "Es natural que continuemos invirtiendo en EEUU, es un mercado crucial"


today 3 h. ago attach_file Events

attach_file Events
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Society
attach_file Politics
attach_file Politics
attach_file Events


ID: 1974812
Add Watch Country

arrow_drop_down